QTMeds

Drug Database Monograph

EBGLYSS 250 mg

PENDING REVIEW

Active Ingredient: LEBRIKIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 63696560

← Back to Prescription Analyzer